KwonS, ThompsonR, DellingerP, et al.: Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg, 2013; 257:8–14.
2.
KosiborodM, InzucchiSE, KrumholzHM, et al.: Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med, 2009; 169:438–446.
3.
FalcigliaM, FreybergRW, AlmenoffPL, et al.: Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med, 2009; 37:3001–3009.
4.
UmpierrezGE, IsaacsSD, BazarganN, et al.: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab, 2002; 87:978–982.
5.
DrazninB, GildenJ, GoldenSH, et al.: Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care, 2013; 36:1807–1814.
6.
FinferS, ChittockDR, SuSY, et al.: Intensive versus conventional glucose control in critically ill patients. N Engl J Med, 2009; 360:1283–1297.
7.
GriesdaleDE, de SouzaRJ, van DamRM, et al.: Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ, 2009; 180:821–827.
8.
KrinsleyJS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc, 2003; 78:1471–1478.
9.
EgiM, BellomoR, StachowskiE, et al.: The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med, 2011; 39:314–321.
10.
KorytkowskiMT, SalataRJ, KoerbelGL, et al.: Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care, 2009; 32:594–596.
11.
MuradMH, CoburnJA, Coto-YglesiasF, et al.: Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab, 2012; 97:49–58.
12.
FinferS, LiuB, ChittockDR, et al.: Hypoglycemia and risk of death in critically ill patients. N Engl J Med, 2012; 367:1108–1118.
13.
KrinsleyJS, GroverA: Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med, 2007; 35:2262–2267.
14.
KosiborodM, InzucchiSE, GoyalA, et al.: Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA, 2009; 301:1556–1564.
15.
MoghissiES, KorytkowskiMT, DiNardoM, et al.: American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract, 2009; 15:353–369.
16.
JacobiJ, BircherN, KrinsleyJ, et al.: Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med, 2012; 40:3251–3276.
17.
UmpierrezGE, HellmanR, KorytkowskiMT, et al.: Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2012; 97:16–38.
18.
CookCB, KongableGL, PotterDJ, et al.: Inpatient glucose control: a glycemic survey of 126 U.S. hospitals. J Hosp Med, 2009; 4:E7–E14.
19.
LevetanCS, PassaroM, JablonskiK, et al.: Unrecognized diabetes among hospitalized patients. Diabetes Care, 1998; 21:246–249.
20.
KosiborodM, InzucchiSE, SpertusJA, et al.: Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation, 2009; 119:1899–1907.
21.
SchmeltzLR, DeSantisAJ, ThiyagarajanV, et al.: Reduction of surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management strategy. Diabetes Care, 2007; 30:823–828.
22.
van den BergheG, WoutersP, WeekersF, et al.: Intensive insulin therapy in the critically ill patients. N Engl J Med, 2001; 345:1359–1367.
23.
KotagalM, SymonsRG, HirschIB, et al.: Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg, 2015; 261:97–103.
24.
MalmbergK, RydenL, EfendicS, et al.: Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol, 1995; 26:57–65.
25.
FurnaryAP, GaoG, GrunkemeierGL, et al.: Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg, 2003; 125:1007–1021.
26.
LazarHL, ChipkinSR, FitzgeraldCA, et al.: Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation, 2004; 109:1497–1502.
27.
De La Rosa GdelC, DonadoJH, RestrepoAH, et al.: Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care, 2008; 12:R120.
28.
UmpierrezGE, SmileyD, JacobsS, et al.: Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care, 2011; 34:256–261.
29.
UmpierrezGE, GianchandaniR, SmileyD, et al.: Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study. Diabetes Care, 2013; 36:3430–3435.
30.
PasquelFJ, KleinR, AdigwemeA, et al.: Metformin-associated lactic acidosis. Am J Med Sci, 2013December10 [Epub ahead of print].
31.
ClementS, BraithwaiteSS, MageeMF, et al.: Management of diabetes and hyperglycemia in hospitals. Diabetes Care, 2004; 27:553–597.
32.
SmileyD, UmpierrezGE: Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci, 2011; 1212:1–11.
33.
SchwartzS, DeFronzoRA: Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: The time has come for GLP-1 receptor agonists!. Diabetes Care, 2013; 36:2107–2111.
34.
GriffithML, BoordJB, EdenSK, et al.: Clinical inertia of discharge planning among patients with poorly controlled diabetes mellitus. J Clin Endocrinol Metab, 2012; 97:2019–2026.
35.
CookCB, SeifertKM, HullBP, et al.: Inpatient to outpatient transfer of diabetes care: planning for an effective hospital discharge. Endocr Pract, 2009; 15:263–269.
36.
UmpierrezGE, ReyesD, SmileyD, et al.: Hospital discharge algorithm based on admission HbA1c for the management of patients with type 2 diabetes. Diabetes Care, 2014; 37:2934–2939.
37.
KlonoffDC, BuckinghamB, ChristiansenJS, et al.: Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2011; 96:2968–2979.
38.
GomezAM, UmpierrezGE: Continuous glucose monitoring in insulin-treated patients in non-ICU settings. J Diabetes Sci Technol, 2014; 8:930–936.
39.
GomezAM, UmpierrezGE, AschnerP, et al.: Comparison of inpatient glycaemic control by continuous glucose monitoring (CGM) and capillary point-of-care (POC) testing in general medicine patients with type 2 diabetes [abstract 57]. Diabetologia, 2013; 56(Suppl 1):S30.
40.
RyanMT, SavareseVW, HipszerB, et al.: Continuous glucose monitor shows potential for early hypoglycemia detection in hospitalized patients. Diabetes Technol Ther, 2009; 11:745–747.
41.
CorstjensAM, LigtenbergJJ, van der HorstIC, et al.: Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients. Crit Care, 2006; 10:R135.
42.
ScottMG, BrunsDE, BoydJC, et al.: Tight glucose control in the intensive care unit: are glucose meters up to the task?. Clin Chem, 2009; 55:18–20.
43.
YamashitaK, OkabayashiT, YokoyamaT, et al.: Accuracy and reliability of continuous blood glucose monitor in post-surgical patients. Acta Anaesth Scand, 2009; 53:66–71.
44.
BoomDT, SechterbergerMK, RijkenbergS, et al.: Insulin treatment guided by subcutaneous continuous glucose monitoring compared to frequent point-of-care measurement in critically ill patients: a randomized controlled trial. Crit Care, 2014; 18:453.
